MRI Prostate Order Form Requirements
The request form should explicitly state: "Multiparametric MRI Prostate with PI-RADS protocol" and include the clinical indication "elevated PSA [specify value] for detection of clinically significant prostate cancer prior to biopsy." 1
Essential Components to Specify on the Order
Primary Request Language
Write on the order form:
- "Multiparametric MRI (mpMRI) Prostate with PI-RADS v2.1 protocol"
- Clinical indication: "Elevated PSA [10.5 ng/mL] - evaluate for clinically significant prostate cancer, biopsy-naïve patient"
- Purpose: "Detection and localization of clinically significant prostate cancer with PI-RADS scoring"
Required Sequences to Document
The order should specify that the study must include 1, 2, 3:
Mandatory sequences:
- High-resolution T2-weighted imaging (T2WI)
- Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps
- Dynamic contrast-enhanced (DCE) MRI sequence
If gadolinium is contraindicated, explicitly request:
- "Biparametric MRI (bpMRI) Prostate with PI-RADS protocol - T2WI and DWI only, no contrast"
- Note: "Gadolinium contraindicated due to [specify reason: renal insufficiency/allergy/other]"
The evidence shows biparametric MRI (without DCE) has comparable diagnostic performance to full multiparametric MRI for detecting clinically significant prostate cancer, with good interobserver reliability (kappa = 0.642 vs 0.644 for mpMRI) 4. This makes it a viable alternative when contrast is contraindicated.
Critical Reporting Requirements to Request
Explicitly ask for:
- PI-RADS assessment category (1-5) for each suspicious lesion
- Sector map localization of up to 4 lesions (categories 3-5)
- Index lesion identification (highest PI-RADS score or largest clinically significant lesion)
- Zone specification (peripheral zone vs. transitional zone) for each lesion 1, 3
Clinical Context Matters
For your biopsy-naïve patient with PSA 10.5 ng/mL, the PI-RADS compliant mpMRI serves to 1:
- Minimize overdiagnosis of indolent disease
- Detect clinically significant prostate cancer requiring treatment
- Guide targeted biopsy strategy based on PI-RADS score
Management will depend on PI-RADS results:
- PI-RADS 1-2: Consider no immediate biopsy if otherwise lower risk; primary care or urologic follow-up
- PI-RADS 3: MRI-directed biopsy (MRDB) target + standard TRUS biopsy recommended
- PI-RADS 4-5: MRDB target + TRUS biopsy strongly recommended
Common Pitfalls to Avoid
Do NOT simply order "MRI Prostate" - this generic request may result in:
- Non-standardized protocols without all required sequences
- Reports lacking PI-RADS scoring
- Inadequate quality for biopsy planning
Do NOT assume contrast will be given - if there are any renal concerns or contrast allergies, proactively specify biparametric protocol to avoid study delays or cancellations.
Do NOT forget to include PSA value and clinical context - radiologists need this information to provide appropriate PI-RADS assessment and guide clinical decision-making 1, 5.
Technical Specifications Worth Noting
While not always necessary to specify on the order form (radiology protocols should handle this), high-quality imaging requires 6:
- 3T magnet preferred (1.5T acceptable with optimized protocols)
- Pelvic phased-array coil (endorectal coil optional, not mandatory)
- PI-RADS v2.1 compliant acquisition parameters
The keys to success are high-quality imaging, standardized PI-RADS reporting, and coordination between radiologists and urologists in multidisciplinary teams 1.